Physician profile
John W Mccarter
NPI 1568445625
$2,246.76
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,364 · 2020: $786 · 2021: $61.13 · 2022: $36.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $321.80 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.47 | 2019-2020 | |
| Pfizer INC. | $229.51 | 2019-2020 | |
| Lilly USA, LLC | $229.13 | 2019-2020 | |
| Novo Nordisk INC | $177.10 | 2019-2020 | |
| Amgen INC. | $157.38 | 2019 | |
| Sanofi-Aventis U.S. LLC | $122.84 | 2019-2020 | |
| Glaxosmithkline, LLC. | $103.54 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $101.57 | 2019-2020 | |
| Amarin Pharma, INC. | $100.82 | 2019-2020 | |
| Abbvie INC. | $97.30 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.86 | 2019-2020 | |
| Astellas Pharma US INC | $70.04 | 2019-2020 | |
| Eisai INC. | $57.68 | 2019-2020 | |
| Qol Medical, LLC | $23.93 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $18.63 | 2019 | |
| Genentech USA, INC. | $14.85 | 2020 | |
| Ibsa Pharma INC. | $14.78 | 2020 | |
| Medtronic USA, INC. | $13.24 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.90 | 2019 | |
| Merck Sharp & Dohme LLC | $12.78 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.36 | 2019 | |
| Bardy Diagnostics, INC. | $10.25 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mccarter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.